Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex

Neurochemical Research

Volumn 25, Issue 6, 2000, Pages 867-873

  Gorini, A ^a   Rancati, A ^a   D'Angelo, A ^a   Devecchi, E ^a   Villa, R F ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

ATP ases; Cerebral cortex; Naloxone; Synaptic plasma membranes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); NALOXONE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC MEMBRANE;

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; CEREBRAL CORTEX; ENZYME ACTIVATION; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; SYNAPTIC MEMBRANES;

EID: 0033900169     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007529826905     Document Type: Article

References (68)

1. New and experimental therapeutic roles for naloxone and related opioid antagonists
2. Calcium depletion of synaptosomes after morphine treatment
3. Enkephalin: A potential modulator of noradrenaline release in rat brain
4. 2+ uptake by opiates in vitro
5. + evoked afflux of putative neurotransmitter in rat brain
6. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine
7. Action of enkephalin analogues and morphine on brain acetylcholine release
8. Nerve cell calcium as a messenger for opiate and endorphine actions
9. 2+-ATPase in brain membrane subfraction
10. The effects of morphine on the endogenous phosphorylation of synaptic plasma membrane proteins of rat striatum
11. Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes
12. Effects of acute and chronic morphine treatment on calmodulin activity of rat synaptosomes and of synaptic membranes of rat cerebral cortex
13. Calcium content and binding in synaptosomal subfractions during chronic morphine treatment
14. Effects of acute and chronic morphine treatments on calcium localization and binding in brain
15. Opioid analgesics and antagonists
16. Opioid receptors
17. Visualization of opiate receptor upregulation by light microscopy autoradiography
18. Autoradiographic localization of μ-and κ -opiate receptors in the forebrain of the rat
19. 1-purinergic autoreceptors have mutually antagonistic effects: A new regulatory mechanism?
20. 2+](i) is decreased by clonidine and dynorphin A(l-13) and increased by iodazoxan
21. Synaptic plasma membranes from rat brain synaptosomes: Isolation and partial characterization
22. Calcium-activated ATPases in presynaptic nerve endings
23. Characterization of calcium-activated and magnesium-activated ATPases of brain nerve endings
24. Synaptosomal nonmitochondrial ATPase activities: Age-related alterations by chronic normobaric intermittent hypoxia
25. Isolation and partial characterization of rat brain synaptic plasma membranes
26. Modifications by hypoxia and drug treatment of cerebral ATPase plasticity
27. Acetylcholinesterase activity of synaptic plasma membranes during ageing: Effect of L-acetylcarnitine
28. A new and rapid colorimetric determination of acetylcholinesterase activity
29. Spectrophotometric assay of cytochrome c oxidase
30. Cytochrome oxidase from beef heart mitochondria
31. Oxidation and reduction of soluble cytochrome c by membrane-bound oxidase and reductase system
32. Lactate dehydrogenase: UV-assay with piruvate and NADH
33. 2+-AT-Pase in enriched nerve-ending plasma membranes
34. Calcium-stimulated adenosine triphosphatases in synaptic membranes
35. 2+-dependent ATPase in rat brain synaptosomes, synaptic membranes, and micromes
36. Altered synaptosomal ATPase activity in rat brain following prolonged in vivo treatment with nicotine
37. Calcium ATPase activities in synaptic plasma membranes of seizure-pronemice
38. Studies on sodium-potassium-activated adenosine triphosphatase. I. Quantitative distribution in several tissues of tha cat
39. A convenient method for the ATPase assay
40. Protein measurement with the Folin phenol reagent
41. Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus
42. Synaptosomal non-mitochondrial ATPase activities and drug treatment
43. Enzyme activities of selected mitochondria from hippocampus and striatum in aging
44. Stimulus-secretion coupling: The concept and clues from chromaffin and other cells
45. The regulation of intracellular calcium in presynaptic nerve terminals
46. Cyclic 3',5-nucleotide phosphodiesterase evidence for and properties of a protein activator
47. The interrelationship between sodium and calcium fluxes across cell membranes
48. 2+ fluxes in resealed synaptic plasma membrane vescicles
49. Calcium transport in a vescicular membrane preparation from rat brain synaptosomes
50. 2+-dependent modulator protein
51. 2+ transport in synaptic membranes
52. +-ATPase from homogenate of synaptosomes and synaptic membrane of rat cerebral cortex
53. Enzyme mitochondrial system during aging: Pharmacological implications
54. The human pharmacology and abuse potential of N-allylnoroxy morphone (naloxone)
55. Naloxone-induced reversal of schizophrenic hallucinations
56. Endorphins β-LPH and ACTH: Biochemical, pharmacological and anatomical studies
57. Effects of naloxone on schizophrenia: Reduction in hallucinations in a subpopulation of subjects
58. Naloxone administration in chronic hallucinating schizophrenic patients
59. Action of naloxone in different types of psychases
60. Seizure and electroencephalographic changes in the newborn period induced by opiates and corrected by naloxone infusion
61. Potentiating effect of morphine on seizures induced by kainic acid in rats. An electroencephalographic study
62. Opioid inhibition of formalin-induced changes in plasma extravasation and local blood flow in rats
63. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal
64. Opioids transiently prevent activation of apoptotic mechanisms following short periods of serum withdrawal
65. Promising pharmacological agents in the management of acute spinal cord injury